Forgot to highlight this paragraph => "Although it’s losing market share to Axiron, Androgel, the TRT market leader enjoying a 65% market share, loses patent protection in 2016. A month’s supply of either product costs $300-$350, or $50 with health insurance. So Axiron’s safety advantage is a necessary differentiator if it’s to avoid price pressure when TRT generics hit the market."
From memory, doesn't Axiron have something like a mere 14% market share; which they achieved from a scratch start three years ago? If they have a safer product then why would their market share not grow more rapidly as a results of these recent developments? In a perverse sort of what these recent adverse market developments may result in Axiron becoming the dominant treatment far faster than they could otherwise? That may translate into a quadrupling of their current market share; which when combined with growth from other markets around the world should make for steady growth in earnings; despite the eventual launch of some generics post the patent expire of Androgel and less off label use.
- Forums
- ASX - By Stock
- ACR
- Ignore the FDA and buy Acrux
Ignore the FDA and buy Acrux
Featured News
Add ACR (ASX) to my watchlist
|
|||||
Last
6.2¢ |
Change
-0.002(3.13%) |
Mkt cap ! $18.02M |
Open | High | Low | Value | Volume |
6.4¢ | 6.4¢ | 6.2¢ | $19.56K | 306.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 165056 | 6.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.4¢ | 63158 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 165056 | 0.062 |
2 | 39093 | 0.060 |
1 | 20000 | 0.059 |
3 | 60723 | 0.058 |
1 | 10000 | 0.055 |
Price($) | Vol. | No. |
---|---|---|
0.064 | 63158 | 1 |
0.066 | 38550 | 1 |
0.067 | 46144 | 4 |
0.068 | 50000 | 1 |
0.069 | 30387 | 2 |
Last trade - 16.10pm 20/08/2024 (20 minute delay) ? |
Featured News
ACR (ASX) Chart |
The Watchlist
CC9
CHARIOT CORPORATION LTD
MD - Shanthar Pathmanathan, Geologist - David Trabert
MD - Shanthar Pathmanathan
Geologist - David Trabert
SPONSORED BY The Market Online